EUVIMEDEUVIMED entdecken
Crossref

Development of Vancomycin Population Pharmacokinetic Models for Pediatric Patients Using a Real-World Web Application Database

Kazutaka Oda iD, Kensuke Shoji iD, Kazuaki Matsumoto, Hideki Kawamura, Yoshio Takesue, Aakari Shigemi, Toshimi Kimura

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Kazutaka Oda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto city, Kumamoto 860-8556, Japan. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Drug Monitoring, Models, Biological. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Japanese Society of Chemotherapy developed practical area under the concentration-time curve (AUC)-guided therapeutic drug monitoring (PAT), a freely available web-based application widely used in Japan to support AUC-guided dosing of vancomycin. Its broad adoption has generated a substantial real-world pharmacokinetic database. Although PAT includes a preliminary pediatric model based on data from American children aged 3 months or older, that model requires further optimization. This study aimed to develop a population pharmacokinetic (popPK) model specifically for Japanese pediatric patients and to compare its performance with existing models.

Methods

We utilized a real-world database collected through PAT between December 2022 and October 2024, comprising 1673 pediatric patients aged 3 months or older. Population pharmacokinetic analysis was performed using nonlinear mixed-effects modeling, with comparisons made against 5 existing models.

Results

The developed model demonstrated strong a priori predictive performance for empirical vancomycin dosing, with a mean prediction error of 0.2 μg/mL and a mean absolute prediction error of 5.6 μg/mL. These results showed no apparent bias. Graphical diagnostics confirmed optimal a priori prediction in the developed model. A posteriori predictive performance—used for Bayesian posterior dosing—was similarly favorable across all models. Notably, 2-point sampling produced significantly different clearance estimates compared with 1-point sampling in 21 of 116 patients (18.1%).

Conclusions

For Japanese pediatric patients aged 3 months or older, the developed popPK model is suitable for both empirical and Bayesian-guided vancomycin dosing. Two-point sampling improves the accuracy of clearance estimation and is recommended when feasible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsDrug MonitoringModels, BiologicalHumansChild, PreschoolInfantChildMaleFemaleDatabases, FactualJapanArea Under CurveBayes TheoremAdolescentInternet

Stichwörter der Autor:innen

applicationarea under the concentration-time curvepopulation pharmacokineticsreal-world databasetherapeutic drug monitoringvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto city, Kumamoto 860-8556, Japan.
  • Department of Infection Control, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto city, Kumamoto 860-8556, Japan.
  • Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Setagaya-ku, Tokyo 157-8535, Japan.
  • Division of Pharmacodynamics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo 105-8512, Japan.
  • Department of Infection Control and Prevention, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima city, Kagoshima 890-8520, Japan.
  • Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

ORCID-Profile: Kazutaka Oda, Kensuke Shoji

Zitieren

APA

Oda, K., Shoji, K., Matsumoto, K., Kawamura, H., Takesue, Y., Shigemi, A., & Kimura, T. (2025). Development of Vancomycin Population Pharmacokinetic Models for Pediatric Patients Using a Real-World Web Application Database. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf087

Vancouver

Oda K, Shoji K, Matsumoto K, Kawamura H, Takesue Y, Shigemi A, et al. Development of Vancomycin Population Pharmacokinetic Models for Pediatric Patients Using a Real-World Web Application Database. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf087

BibTeX
@article{Oda2025,
  author = {Oda, Kazutaka and Shoji, Kensuke and Matsumoto, Kazuaki and Kawamura, Hideki and Takesue, Yoshio and Shigemi, Aakari and Kimura, Toshimi},
  title = {Development of Vancomycin Population Pharmacokinetic Models for Pediatric Patients Using a Real-World Web Application Database},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf087}
}
Kostenlos starten →